MMP2 and cutaneous melanoma: Multiple studies have revealed an increased expression of MMP-2 in TME including cancer of the colorectum, ovaries, breast, prostate, bladder, lung, and pancreas, in addition to primary skin melanoma and central nervous system (CNS) malignancies (Table 2).